Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin …
RK Goudar, Q Shi, MD Hjelmeland, ST Keir… - Molecular cancer …, 2005 - AACR
Malignant gliomas are highly lethal tumors that display striking genetic heterogeneity. Novel
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …
Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin …
RK Goudar, Q Shi… - Molecular cancer …, 2005 - mdanderson.elsevierpure.com
Malignant gliomas are highly lethal tumors that display striking genetic heterogeneity. Novel
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …
Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin …
RK Goudar, Q Shi, MD Hjelmeland… - Molecular cancer …, 2005 - pubmed.ncbi.nlm.nih.gov
Malignant gliomas are highly lethal tumors that display striking genetic heterogeneity. Novel
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …
[PDF][PDF] Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of …
RK Goudar, Q Shi, MD Hjelmeland, ST Keir… - Mol Cancer …, 2005 - academia.edu
Malignant gliomas are highly lethal tumors that display striking genetic heterogeneity. Novel
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …
[PDF][PDF] Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of …
RK Goudar, Q Shi, MD Hjelmeland, ST Keir… - Mol Cancer Ther, 2005 - Citeseer
Malignant gliomas are highly lethal tumors that display striking genetic heterogeneity. Novel
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …
Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin …
RK Goudar, Q Shi, MD Hjelmeland, ST Keir… - Molecular Cancer …, 2005 - europepmc.org
Malignant gliomas are highly lethal tumors that display striking genetic heterogeneity. Novel
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …
[PDF][PDF] Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of …
RK Goudar, Q Shi, MD Hjelmeland, ST Keir… - Mol Cancer …, 2005 - researchgate.net
Malignant gliomas are highly lethal tumors that display striking genetic heterogeneity. Novel
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …
therapies that inhibit a single molecular target may slow tumor progression, but tumors are …